A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

Clinical Trial Details

USOR 17038

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Lung Cancer
Study Type: Interventional
Phase: Phase I
Study Start Date: 09/25/17
Study Completion Date: 03/2020

A Study of MGCD516 in Patients With Advanced Cancer and Any Loss of function mutation in CBL Genetic Alteration in AXL.

NCT Number
NCT02219711
Principal Investigator(s)
John Wallmark, MD
Sponsor(s)
Mirati Therapeutics Inc.
Participant Eligibility
  • Age: 18 - No Maximum
  • Gender: Male, Female

Location

  • Shady Grove Adventist Aquilino Cancer Center
    9905 Medical Center Drive
    Rockville, MD 20850
    Main: 240-826-6297

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.